Free Trial
LON:CTEC

ConvaTec Group (CTEC) Share Price, News & Analysis

ConvaTec Group logo
GBX 219.80 -1.20 (-0.54%)
(As of 12:09 PM ET)

About ConvaTec Group Stock (LON:CTEC)

Key Stats

Today's Range
218.61
221.60
50-Day Range
213.40
264.40
52-Week Range
211.80
295.20
Volume
2.56 million shs
Average Volume
6.80 million shs
Market Capitalization
£4.51 billion
P/E Ratio
3,663.33
Dividend Yield
2.27%
Price Target
GBX 301.67
Consensus Rating
Buy

Company Overview

ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. It also provides ostomy care solutions, including devices, accessories, and services for people with a stoma resulting from colorectal cancer, inflammatory bowel disease, and bladder cancer. In addition, the company offers continence care products and services for people with urinary continence issues related to spinal cord injuries, multiple sclerosis, spina bifida, and other causes, as well as critical care devices and products used in intensive care units and hospital settings. Further, it provides infusion care solutions comprising disposable infusion sets for diabetes insulin pumps, or for pumps used in continuous subcutaneous infusion treatments for conditions such as parkinson's disease. The company sells its products to pharmacies, hospitals, and other acute and post-acute healthcare service providers directly or through distributors and wholesalers. It serves a range of customers, including healthcare providers, patients, and manufacturers. ConvaTec Group PLC was founded in 1978 and is headquartered in London, the United Kingdom.

ConvaTec Group Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
48th Percentile Overall Score

CTEC MarketRank™: 

ConvaTec Group scored higher than 48% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    ConvaTec Group has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 3 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    ConvaTec Group has received no research coverage in the past 90 days.

  • Read more about ConvaTec Group's stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of ConvaTec Group is 3,663.33, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 112.36.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of ConvaTec Group is 3,663.33, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 87.05.

  • Price to Earnings Growth Ratio

    ConvaTec Group has a PEG Ratio of 0.93. PEG Ratios below 1 indicate that a company could be undervalued.

  • Price to Book Value per Share Ratio

    ConvaTec Group has a P/B Ratio of 2.71. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Short Interest

    There is no current short interest data available for CTEC.
  • Dividend Yield

    ConvaTec Group pays a meaningful dividend of 2.23%, higher than the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    ConvaTec Group does not have a long track record of dividend growth.

  • Dividend Coverage

    The dividend payout ratio of ConvaTec Group is 8,333.33%. Payout ratios above 75% are not desirable because they may not be sustainable.

  • Read more about ConvaTec Group's dividend.
  • Short Interest

    There is no current short interest data available for CTEC.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for ConvaTec Group this week, compared to 0 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, ConvaTec Group insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    19.65% of the stock of ConvaTec Group is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    69.05% of the stock of ConvaTec Group is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about ConvaTec Group's insider trading history.
Receive CTEC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ConvaTec Group and its competitors with MarketBeat's FREE daily newsletter.

CTEC Stock News Headlines

ConvaTec (CTEC) Gets a Buy from UBS
Could This Tiny Device Help You Make an Extra $30k a Year?
I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more than $9 trillion. That’s nearly 10 times more money than the market caps of Tesla… SpaceX… PayPal… Neuralink… and X… COMBINED.
Jefferies Remains a Buy on ConvaTec (CTEC)
ConvaTec’s Strong Performance and Positive Outlook Drive Buy Rating
See More Headlines

CTEC Stock Analysis - Frequently Asked Questions

ConvaTec Group's stock was trading at GBX 244.20 at the beginning of 2024. Since then, CTEC shares have decreased by 10.0% and is now trading at GBX 219.80.
View the best growth stocks for 2024 here
.

ConvaTec Group PLC (LON:CTEC) issued its quarterly earnings results on Friday, February, 28th. The company reported $12.00 earnings per share (EPS) for the quarter, missing the consensus estimate of $12.70 by $0.70. ConvaTec Group had a net margin of 6.96% and a trailing twelve-month return on equity of 9.34%.

Shares of CTEC stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that ConvaTec Group investors own include EnQuest (ENQ), Centamin (CEY), Lloyds Banking Group (LLOY), Oxford Biomedica (OXB), Tullow Oil (TLW), Barclays (BARC) and Vodafone Group Public (VOD).

Company Calendar

Last Earnings
2/28/2020
Ex-Dividend for 10/4 Dividend
8/22/2024
Dividend Payable
10/04/2024
Today
12/23/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Medical Instruments & Supplies
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
10,000
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
GBX 301.67
High Stock Price Target
GBX 310
Low Stock Price Target
GBX 290
Potential Upside/Downside
+37.2%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
3 Analysts

Profitability

Net Income
£153.20 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£2.20 billion
Cash Flow
GBX 12.92 per share
Book Value
GBX 81 per share

Miscellaneous

Outstanding Shares
2,050,000,000
Free Float
N/A
Market Cap
£4.51 billion
Optionable
Not Optionable
Beta
0.64
Unlock the Potential in Options Trading Cover

Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Keep reading to learn how options trading can help you use the market’s volatility to your advantage.

Get This Free Report

This page (LON:CTEC) was last updated on 12/23/2024 by MarketBeat.com Staff
From Our Partners